PARTNERS

SAFE is an international project involving partners across South European Countries (Italy, Portugal and Spain). The involved countries present one of the biggest challenges on increasing awareness related to Antimicrobial Resistance among the general population. As demonstrated in the last European survey published in 2018 a knowledge gap is still present mostly in South Europe countries but little is done at educational level to mitigate this problem.

SAFE involves academical partners (Università degli Studi di Napoli Federico II, Universitat de Barcelona, Universidade do Porto, Instituto de Desarrollo Profesional, Universidad Complutense de Madrid, Escola Universitária Vasco da Gama), research partners (ISGlobal), private enterprises (Roche Diagnostics SL) and public administrations (Institut Català de la Salut), as well as national microbiology networks (Sociedad Española de Microbiología), covering Italy, Portugal and Spain, South European countries with high incidence of infections caused by resistant bacteria and lowest knowledge on this topic.

isglobal

ISGlobal (Barcelona Institute for Global Health)

The Barcelona Institute for Global Health, ISGlobal, is the fruit of an innovative alliance between “la Caixa”, academic institutions and government bodies to contribute to the efforts undertaken by the international community to address the challenges in global health.

ISGlobal is a consolidated hub of excellence in research that has grown out of work first started in the world of health care by the Hospital Clínic and the Parc de Salut MAR and in the academic sphere by the University of Barcelona and Pompeu Fabra University. The pivotal mechanism of its work model is the transfer of knowledge generated by scientific research to practice, a task undertaken by the institute’s Education and Policy and Global Development departments.

Its ultimate goal is to help close the gaps in health disparities between and within different regions of the world.

Dr. Clara Ballesté: Clara is a Doctor in Biology from the University of Barcelona. She has a degree in Human Biology from the Pompeu Fabra University where she also completed a Master in Pharmaceutical and Biotechnology Industry. Before starting the doctorate, she worked for two years as a researcher at the R&D centre of the pharmaceutical laboratories Ferrer Internacional, S.A. in new antibacterial discovery projects. Subsequently, and in this same context, she worked on the search for new antituberculosis drugs at the Biosafety 3 facilities of the Animal Health Research Centre (CreSA) in Bellaterra.

In 2011 she began as a PhD student at ISGlobal in the research group “Molecular basis of antibiotic resistance” led by Dr. Jordi Vila. His research was focused on studying the relationship between resistance acquisition to the family of antibiotics called quinolones and their effect on virulence in Salmonella enterica.

She currently assumes the role of Coordinator of the Antibiotic Resistance Initiative and is Project Assistant of Dr. Vila’s research group.

Marina Tarrús: Marina Tarrús is Scientific Outreach Technician at ISGlobal. Her background includes a bachelor in Biotechnology (Molecular Biology specialization) from the Universitat de Barcelona; MSc. in Scientific, Medical and Environmental Communication; postgraduate degrees in Environment and Infrastructures for a Paradigm Shift and in Design for sustainability by Universitat Oberta de Catalunya.

Her main fields of interest are scientific outreach through arts and citizen science methodologies, sustainable development and biotechnology. With experience in scientific journalism (Vall d’Hebron Institute of Research), scientific scenography (Science and Theatre Institute) and with the role of Expert for Sustainable Development and Biotechnology (Environmental Movement of Vojvodina), she has worked in Spain, The Netherlands and the Republic of Serbia promoting projects for community engagement through citizen science and artistic outreach.

Currently she works in the Unit for Scientific Outreach and Innovation of ISGlobal as an outreach technician in projects on citizen science and participatory research as BiblioLab, Park(ing)Day Barcelona, and Researcher’s Night.

Universitat de Barcelona - Facultat de Farmàcia i Ciències de l’Alimentació

Universitat de Barcelona – Facultat de Farmàcia i Ciències de l’Alimentació

The University of Barcelona (UB) is a public university located in the city of Barcelona, Catalonia in Spain. UB is the principal centre of university research in Spain and has become a European benchmark for research activity, both in terms of the number of research programs it conducts and the excellence these have achieved.

Closely linked to the history of Barcelona and Catalonia, the UB combines the values of tradition with the fact of being an innovative institution of excellence in the teaching field. It is an urban, open, cosmopolitan university like the city of Barcelona itself.

Otherwise, the Faculty of Pharmacy and Food Sciences of the University of Barcelona is the only public university center in Catalonia where the degree in pharmacy is taught. It also teaches human nutrition and dietetics, and food science and technology. The faculty has as its identifying logo the door of Gaudí that corresponds to the door of the old Güell property.

Dr. David Miñana-Galbis: David is a Doctor in Biology from the Universitat de Barcelona (UB). He has a degree in Biological Sciences from the Universitat de València and a Master in AIDS from the UB and the Instituto de Salud Carlos III (Majadahonda, Madrid). As a PhD student, his research was focused on the phenotypic and genotypic diversity of the genus Aeromonas. He did a one year postdoctoral stay in the Universitat Autònoma de Barcelona (UAB) focused on the development of non-viral vector prototypes for gene therapy, adapted to the treatment of chronic viral diseases.

His background includes research in HIV, bacterial virulence markers, genomics, population genetics, phylogeny and taxonomy, with more than 30 publications, and an extensive experience in teaching Microbiology, Pharmaceutical and Food Biotechnology and the direction of two doctoral theses.
Currently, he is an Associate Professor in Microbiology at the UB, his research is mainly focused on genetic populations, genomics and genetic markers of Helicobacter pylori, and he is the Coordinator of the Small World Initiative (SWI) / Tiny Earth at the UB.

Denisa Cont: Denisa has a degree in Pharmacy from the Faculty of Pharmacy and Food Sciences at the University of Barcelona. Currently, She is doing a master’s degree in Advanced Microbiology at the Faculty of Biology also in the University of Barcelona.

Roche Spain

Roche Spain

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. In 2019, Roche invested CHF 11.7 billion in R&D and posted sales of CHF 61.5 billion.

Miguel Alvarez Tejado is Doctor in Biology from the University Complutense of Madrid. His background has scientific research in the areas on Immunology and Signal transduction of angiogenesis in different Hospitals in Madrid. After a brief period of assistant professor at University Complutense of Madrid, he is now working in Roche. In Roche he developed sales, project management, innovation and marketing activities in the areas of Roche Applied Science and now Molecular Solutions, covering molecular, tissue and next generation sequencing solutions.

Francisco Aguilar Álvarez has studied business and corporate communication and advertising at EADA Business School Barcelona and IDEC-Universitat Pompeu Fabra Business School Barcelona. He has developed his entire professional career within Roche’s Diagnostics division where he has managed corporate communication from local areas in Spain to regional areas in Latin America, being part of global communication leadership teams and participating in various global digital communication projects.

Patricia Doliwa de la Iglesia holds a degree in Pharmacy from the University of Navarra and studied a Master in Business Administration from Universidad de Deusto and a Management Development Program from IESE. After a period as assistant in the Pharmacy Lab in Hospital Galdacano and stays in pharmacies as a deputy pharmacist, her career has been defined on Marketing and Sales focused on motivation and team leadership. Actually, she is Marketing Segment Manager of Microbiology and Blood Banks in Roche and collaborates as a teacher in the ESAME Pharmaceutical Business School.

Università degli Studi di Napoli Federico II – Dipartimento di Medicina Molecolare e Biotecnologie mediche

Università degli Studi di Napoli Federico II – Dipartimento di Medicina Molecolare e Biotecnologie mediche

The Department of Molecular Medicine and Medical Biotechnology (DMMBM) was established in January 2013 to implement the new organizational structure of the University of Naples Federico II. The facilities for research and teaching of the DMMBM are mostly located within the campus of the Medical School. The DMMBM carries out research activities in the following fields: structure and function of biological molecules and their involvement in the pathogenesis of human diseases, development of innovative biotechnological approaches for prevention, diagnosis and treatment of human diseases.

Teachers and researchers of the DMMBM contribute to the pre- and post- graduate teaching and training in Medicine and in Medical Biotechnology, through the organization of Bachelors, Masters, Specialization and PhD Courses. To carry out research and teaching activities, scientists and teachers of the DMMBM also contribute to the activity welfare of the University Hospital Federico II, in particular via the Departments of Integrated Activities (DAI) such as the Departments of Laboratory and Transfusional Medicine.

Maria Rosaria Catania has a Degree in Biological Sciences from University of Naples Federico II.
She is specialist in Microbiology and Virology and PhD in Microbiological Sciences from University of Campania Luigi Vanvitelli. She currently is an associate professor of Microbiology and Clinical Microbiology at Department of Molecular Medicine and Medical Biotechnology, University Federico II of Naples. She manages the Unit of Bacteriology and Micology of Azienda Ospedaliera of University Federico II. Maria Rosaria is a member of Editorial Board of: Mediators in inflammation, and BMC Infectious Diseases.

Emanuela Roscetto actually is a researcher of Microbiology and Clinical Microbiology (MED/07) at the Department of Molecular Medicine and Medical Biotechnology – University of Naples Federico II. She has: Degree in Biological Sciences from the University of Naples Federico II; PhD in Genetics and Molecular Medicine from the University of Naples Federico II; Specialization in Microbiology and Virology, from the University Federico II of Naples.

Emanuela Roscetto is a member of Editorial Board of Mediators in inflammation.

The research activities of Maria Rosaria Catania and Emanuela Roscetto mainly are focused on the anti-bacterial and anti-biofilm effects of unconventional antimicrobial strategies and on the characterization of antimicrobial resistant bacteria.

Paulina Corral:  PhD in Molecular Biology and Biomedicine by the University of Sevilla in Spain, where she studied the cultivable microbial biodiversity of hypersaline environments. During her postdoctoral stays, Dr. Corral developed her projects on bioprospecting extreme environments for drug discovery at the National Research Council of Italy, and thereupon, the emergence and evolution of bacterial pathogens at the School of Medicine in the University of Central Florida in USA. Currently, her research is focused on the functional, metabolic and genetic diversity of microbial communities in natural environments for the development of novel therapeutics candidates by multi-omics approaches.

Universidad Complutense de Madrid

The Complutense University of Madrid (UCM) is one of the largest and oldest Universities in the world. It shares a Campus of Excellence with the Polytechnic University, conforming one of the most important academic and research hubs in Spain.

It is located on a sprawling campus that occupies the entirety of the Ciudad Universitaria district of Madrid, with annexes in the district of Somosaguas in the neighboring city of Pozuelo de Alarcón. It is named after the ancient Roman settlement of Complutum, now an archeological site in Alcalá de Henares, east of Madrid.

In recent years, the roster of alumni comprises recipients of the Nobel Prize (7), Prince of Asturias Awards (18), Miguel de Cervantes Prize (7), as well as European Commissioners, Presidents of the EU Parliament, European Council Secretary General, ECB Executive Board members, NATO Secretary General, UNESCO Director General, IMF Managing Director, and Heads of State.

Prof. Bruno González-Zorn DVM, PhD is Head of the Antimicrobial Resistance Unit (ARU) at the Complutense University in Madrid, and interdisciplinary team with a research focus on antimicrobial resistance from a One Health perspective. Further, he is Adjunct Professor of Biotechnology at the University for Development Studies in Ghana. He gained his DVM in 1996 studying in Spain and Germany and his european PhD in 2001.

After his Postdoc at the Pasteur Institute in Paris he received a Ramon y Cajal tenure-track contract from the Spanish Ministry of Science to return to Spain. He achieved in 2008 his position as Professor in Complutense University of Madrid. In 2011 he was awarded the National Microbiology Award, the bianual Jaime Ferran Award from the Spanish Society for Microbiology and in 2018 de National Antimicrobial resistance award from the Ministry of Health. Currently he leads his team working on molecular microbiology and the ecology of antimicrobial resistance in Madrid.

His research interests focus on the role the ecology of antimicrobial resistance, including humans, animals, food and the environment, focusing his research on genomics from a One Health perspective. He was the former President of the Molecular Microbiology Group of the Spanish Society for Microbiology and active collaborator since its creation of MicroMundo. He is part of numerous Committees on Antimicrobial Resistance in National and International Institutions.

Sociedad Española de Microbiología

The Spanish Society for Microbiology (SEM) was founded in 1946 as a non-profit Scientific Society for the promotion of Microbiology research and social outreach. It is the major association of Microbiologists devoted to basic research in the field, comprises 11 specialized divisions, holds a biannual National Congresses, Courses and the prestigious Jaime Ferran Prize. SEM is a partner of FEMS and IUMS.

The Education and Communication Division of SEM in collaboration with PRAN/AEMPS launched the SWI@Spain/MicroMundo network in Spain, and expanded it to Portugal and other European countries, in collaboration with Tiny Earth in the USA. MicroMundo is a Citizen Science programme that aims to disseminate scientific culture on antimicrobial resistance and OneHealth, by using a service-learning strategy that links community service to academic activity.

Víctor J. Cid, PhD, is a Professor of Microbiology at the Faculty of Pharmacy at UCM. He co-leads a research team on cell signaling and humanized yeast for the study of genes related to human disease, such as cancer and bacterial infections. He obtained his PhD in 1996 at UCM , followed by a postdoctoral position at the University of California at Berkeley.

He is member of the steering committee of the Spanish Society for Microbiology (SEM), and of the FEMS Grant Committee. From the SEM Education and Communication Group, he leads MicroMundo, a Citizen Science & Service-Learning Project for the dissemination of the proper use of antibiotics based on a service-learning pedagogic strategy, the Spanish partner of the USA matrix networks Tiny Earth network.

University of Coimbra

University of Coimbra was founded in 1290 and constitutes a reference in higher education and scientific research in Portugal, with excellent academic reputation recognized worldwide. It includes 8 Faculties and 40 research centres, providing teaching and conducting research in almost all study fields – Exact Sciences and Engineering, Life Sciences, Architecture, Medicine, Social Sciences, Humanities and Sports, as well as several structures devoted to promote science and technology, culture and sports. The offer in technological research makes UC an undeniable reference in R&D in Portugal, which highlights the excellence of work developed by the R&D units of UC, considered in 2019 the most prolific Portuguese university in terms of submitted patents and cumulatively, more than 50% of 160+ patents and patent pending portfolio is already licensed to companies for commercialization purposes. UC stands out as the most entrepreneurial academy with many spin offs generated in healthcare or ICT applied to healthcare mainly based on R&D developed on its academy.

Moreover, amongst the many international collaborations that could be mentioned related with healthy ageing, a special mention has to be done to EITHealth. UC as the unique Portuguese Core Partner of this 140+ consortia has consistently been developing a diverse number of (educational, accelerator, innovation) projects partnering the most prestigious companies, hospitals and academies in Europe addressing healthy ageing and has been the most active region within the developing countries in the consortia, both in number as budget wise of annually projects. UC is the coordinator of the first Reference Site on Active and Healthy Ageing in Portugal.

University School Vasco da Gama (EUVG)

University School Vasco da Gama (EUVG) is a private university located in the city of Coimbra, Portugal, distinguished by being the only university in the central region of Portugal, where both the master’s degree in Veterinary Medicine and bachelor’s degree in Biovetererinary Sciences are taught.

EUVG’s logo is closely related to the age of Portuguese discoveries and the remarkable explorer Vasco da Gama, which greatly represents the seek for the unknown through the development and satisfaction of an unquenchable thirst for knowledge. EUVG’s mission is promoting innovation, internationalization and communication, transfer of knowledge and education in science, which is the rationale behind EUVG’s motto «Mundo, Mundos Novos Dare».

EUVG has the only R&D veterinary unit – Centro de Investigação Vasco da Gama (CIVG) – in the central region of Portugal.

EUVG has a close engagement both with local communities and society in general, as aiming to address long-term societal challenges, namely in the antimicrobial resistance field as part of the citizen project MicroMundo, a partner of Tiny Earth.

Eduarda Silveira: has a degree in Pharmaceutical Sciences from University Fernando Pessoa, Porto, Portugal. She is a PhD in Pharmaceutical Sciences, specialized in Microbiology, from University of Porto, Portugal. In 2010 she began her PhD at Microbiology Laboratory, University of Porto, Faculty of Pharmacy, UCIBIO/REQUIMTE – Research Laboratory in the research group “Antimicrobial resistance” led by Professor Luísa Peixe. Her research was focused on studying molecular epidemiology of antimicrobial resistance or tolerance (antibiotics, metals and desinfectants) in Enterococcus from different origins. Currently, she works as Assistant Professor and Coordinator of the R&D unit at University School Vasco da Gama (EUVG) and is an Assistant Professor at Faculty of Pharmacy of University of Coimbra. Moreover, she is the coordinator of MicroMundo, a partner of Tiny Earth at center region of Portugal.

Sofia Anastácio: has a degree in Veterinary Medicine and a Master in Promotion/Eduaction in Health from the University of Trás-os-Montes e Alto Douro, Vila Real, Portugal. She is a PhD in Pharmaceutical Sciences, specialized in Microbiology and Parasitology, from University of Coimbra, Portugal. She worked in a diagnostic veterinary laboratory for 6 years in Santarém, Portugal and this experience allowed her to perceive antimicrobial resistance in animal health as a serious and rising threat to global public health. Currently, she is an Assistant Professor and member of University School Vasco da Gama (EUVG) Direction Board. Moreover, she is engaged with the organizing committee of MicroMundo, a partner of Tiny Earth, at EUVG.

Institut de Desenvolupament Professional (IDP-ICE)

The Institute of Educational Sciences of the University of Barcelona, now Institute of Professional Development (IDP-ICE), was founded in 1969 to support the intellectual and cultural development of all those involved in the educational field.

Its main goals are to offer both face-to-face and online training to professors and teachers of all educational levels, as well as educational and research advice, in order to improve the performance of all those involved in the teaching-learning process.

Face-to-face training has been one of the institute’s main activities since its foundation, and online training was incorporated in 2004 when its online courses program for teachers began. This means more than 50 years of experience in face-to-face training and more than 15 years of experience in online training.

The IDP-ICE works together with all the faculties and other units of the University of Barcelona. And also coordinates its activities with other public and private institutions through collaboration agreements.

Among other activities, the various sections that are part of the IDP-ICE are responsible for:

– Analyze the training needs of professors and teachers, and design training programs appropriate to those needs.

– Promote innovation in education.

– Promote, advise, direct and coordinate research in all areas of the institute’s activity, especially educational research.

– Develop protocols for evaluation, publication and dissemination of good practices.

– Develop teaching materials in various formats.

Dra. Lissette Fernández Núñez: Lissette is a Doctor in Psychology from the University of Barcelona. Advisor and trainer in qualitative research methodologies and in the development of research projects. Coordinator of online training activities at the Institute of Professional Development (IDP-ICE) of the University of Barcelona (Spain).

Lluís Casas Sala: Lluís is a primary school teacher, has a degree in art history and studied a Master in teacher training from the University of Barcelona. He has worked as primary teacher and also as a teacher trainer for more than 20 years for the Ministry of education in Catalonia and the IDP of the University of Barcelona. He is currently the Head of the K-12, secondary and vocational training, and coordinates the teacher training actions in these stages at the IDP.

University of Porto

The Faculty of Pharmacy of the University of Porto (FFUP) is the oldest Faculty of Pharmacy in Portugal. It was created in 1921 and continued the traditions of the School of Pharmacy, which was created in 1836. FFUP is a higher education institution focused on teaching and research in the area of Pharmaceutical Sciences. In addition to the transmission of scientific knowledge and skills, FFUP has a continuous concern with the human and ethical domains, training professionals of excellence in the different areas of Pharmaceutical Sciences. The training courses offered by FFUP are constantly updated, aiming the rigour and quality of teaching, as well as its adaptation to the demands and needs of the labour market. The FFUP offers diversified courses, including the Integrated Master degree in Pharmaceutical Sciences, seven second cycles of studies and seven third cycles of studies, some of them in collaboration with other institutions. It also promotes pedagogical, scientific and technical exchanges with national and international institutions, and develops extracurricular and professional training sessions. FFUP is also aware of its social responsibilities, providing public services that consolidate its active role among the local society. FFUP is extremely active and productive and occupies a top place in the ranking of University of Porto as far as the publication of papers indexed in prestigious international scientific journals are concerned. All the academics are integrated in Research Units classified by FCT either as very good, or excellent.

Luísa Peixe is Associate Professor at FFUP, and leader of BACT_DRUGS research lab at UCIBIO@REQUIMTE Research Unit (https://www.requimte.pt/ucibio/research-groups/lab/bactdrugs). She holds several positions in international institutions, including member of Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) scientific board, and Biological Hazards panel of European Food Safety Authority (EFSA). L. Peixe has a large expertise on different clinically relevant bacterial groups, with focus on features involved on their adaptability to different niches and stressors (e.g. ecology and dynamics of antibiotic resistance) and pathogenicity. The adaptability and deleterious effect of low urinary tract bacteria constitutes the more recent interest. She has a longstanding collaboration with hospitals in support of detection and tracing of multidrug-resistant bacteria. She is the coordinator of MicroMundo in Portugal.

Filipa Grosso holds a PhD in Pharmaceutical Sciences with Microbiology Specialization (2012). Her research work has been focused on the molecular epidemiology of antibiotic resistant bacteria from clinical and non-clinical settings. In addition, she has been involved in the characterization of virulence features responsible for the success of pathogenic bacteria, in particular biofilm production and capsular sugar composition. She belongs to the organizing committee of MicroMundo.